Related Experiment Video
Updated: Jun 7, 2026
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Flow cytometric detection of platelet activation in patients undergoing diagnostic and interventional coronary
R Voss1, T Scarlat, A Matzdorff
1Department of Internal Medicine, Division of Cardiology, University of Giessen, Germany.
Insights
Aspirin reduced platelet activation during diagnostic angiography. However, platelet activation increased significantly after coronary angioplasty, even with aspirin treatment, indicating its limited efficacy in this invasive procedure.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Interventional Cardiology
Background:
- Platelet activation is crucial in thrombosis and hemostasis.
- The activated GPIIb/IIIa complex is a key marker of in vivo platelet activation.
- Coronary angiography and angioplasty are procedures that can induce platelet activation.
Purpose of the Study:
- To investigate the expression of the activated GPIIb/IIIa complex as an indicator of in vivo platelet activation.
- To assess the effect of aspirin on platelet activation before and after coronary angiography/angioplasty.
Main Methods:
- Studied 30 patients undergoing coronary procedures, divided into three groups based on aspirin treatment.
- Utilized flow cytometry to identify platelets and measure activated GPIIb/IIIa complex expression.
- Compared platelet activation levels before and after diagnostic coronary angiography and angioplasty.
Main Results:
- Cardiac catheterization increased mean anti-GPIIb/IIIa fluorescence and the percentage of activated platelets.
- Aspirin significantly inhibited the increase in platelet activation during diagnostic angiography.
- The angioplasty group showed the greatest increase in platelet activation despite aspirin administration.
Conclusions:
- Aspirin effectively inhibits platelet activation during diagnostic coronary angiography.
- Coronary angioplasty leads to substantial platelet activation, which is not fully prevented by aspirin.
- Further strategies may be needed to manage platelet activation during complex interventional procedures.
Abstract:
In 30 patients we investigated the expression of activated GPIIb/IIIa-complex as an indicator of in vivo platelet activation before and after coronary angiography/angioplasty. Patients were divided into three groups according to aspirin treatment: group I: patients having a diagnostic coronary angiography without aspirin (n = 6); group II: patients having a diagnostic coronary angiography with low dose aspirin therapy (n = II); group III: patients having a coronary angioplasty with low dose aspirin therapy plus aspirin i.v. (n = 13). Platelets were identified in a flow cytometer by their characteristic light scatter profile and binding of anti-GP Ib, and activated platelets by an antibody to the activated GP IIb/IIIa. Cardiac catheterization lead to an increase of the mean anti-GP IIb/IIIa-fluorescence of the platelets and of the percentage of platelets with an anti-IIb/IIIa-FL exceeding a fixed threshold value (subpopulation). While aspirin substantially inhibited the increase induced by diagnostic angiography, the increase in the angioplasty group was the greatest of all groups despite aspirin.
